Commissioning disputes, clinical contractor conflicts, and internal governance matters — where the outcome must protect both the Trust's commercial position and the continuity of patient care. Independence of the neutral is a governance requirement, not merely a preference.

Licensing disputes, co-development breakdowns, royalty disagreements, and life sciences M&A earn-out conflicts — where the value of a pipeline asset can turn on a single Expert Determination, and litigation would take longer than the patent life.

CRO-sponsor disputes, clinical trial termination claims, IP ownership conflicts post-merger, and technology transfer failures — where disputes arise in commercially early-stage contexts that cannot sustain the cost of full arbitration.

Provider-insurer disputes, tariff disagreements, fraud liability claims, and the complex multi-party coverage disputes that arise when private medical insurance intersects with NHS delivery and regulatory requirements.

Expert clinical appointment, neutral selection for healthcare proceedings, and independent assessment for clients — where healthcare law firms need clinical expertise that is genuinely independent and verifiably neutral.

Independent review of regulatory enforcement disputes, professional standards conflicts, and governance disagreements within healthcare institutions — where the independence of the neutral is the primary requirement and cannot be compromised.